MEDICINES DISCOVERY CATAPULT LIMITED
Company Information
- Company Number
- 09928547
- Registered Address
- Block 35g, Mereside Alderley Park, Alderley Edge, Macclesfield, Cheshire, England, SK10 4ZF
- Status
- Active
- Employee Count
- 145
- Turnover
- £17,191,000
- EBITDA
- £1,050,000
Additional Details
- Website
- https://cfamr.org.uk/
- Company Type
- Private company limited by guarantee without share capital
- Incorporated On
- 23 December 2015
- Nature of Business
- 72110 - Research and experimental development on biotechnology
- Industries
- Life Sciences And Medical Technology
- Region
- North West
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Company Review
Trend Analysis
The average time taken for MEDICINES DISCOVERY CATAPULT LIMITED to pay invoices has remained relatively stable over the past three periods, with a slight increase from 16 days to 18 days. However, the percentage of invoices paid within 30 days has consistently remained high at 97-99%, indicating a strong commitment to timely payments to suppliers.
Volatility Analysis
The volatility of MEDICINES DISCOVERY CATAPULT LIMITED's payment patterns is low, with a consistent trend of paying invoices within 30 days and minimal fluctuations in the percentages of invoices paid within 31-60 days and later than 60 days.
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Apr 2023 - 30 Sept 2023 | 23 Oct 2023 | 17 | 99% | 1% | 0% | 0% |
| 01 Oct 2022 - 31 Mar 2023 | 28 Apr 2023 | 18 | 97% | 3% | 0% | 0% |
| 01 Apr 2022 - 30 Sept 2022 | 29 Nov 2022 | 18 | 99% | 1% | 0% | 0% |
| 01 Oct 2021 - 31 Mar 2022 | 21 Apr 2022 | 16 | 99% | 1% | 0% | 0% |
| 01 Apr 2021 - 30 Sept 2021 | 28 Oct 2021 | 16 | 97% | 2% | 1% | 1% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
30 days from invoice date
Were there any changes to the standard payment terms in the reporting period?
No
Any other information about payment terms
N/A
Maximum contractual payment period agreed
30
Dispute Resolution Process
All disputes should be sent to accountspayable@md.catapult.org.uk and will be responded to within 24 hours
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
✅
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
MEDICINES DISCOVERY CATAPULT LIMITED is a not-for-profit organization based in the United Kingdom that focuses on accelerating the discovery and development of new medicines. The company was established in 2012 and is funded by the UK government's Department for Business, Energy and Industrial Strategy.
The main aim of MEDICINES DISCOVERY CATAPULT LIMITED is to bridge the gap between academic research and commercial drug development, by providing expertise, technology and facilities to support the discovery and development of new medicines. The company works closely with academic institutions, biopharmaceutical companies, and other research organizations to identify and develop new treatments for diseases.
One of the key activities of MEDICINES DISCOVERY CATAPULT LIMITED is its sustainability program. The company is committed to reducing its environmental impact and promoting sustainable practices in the pharmaceutical industry. This includes reducing waste, conserving energy, and using sustainable materials in their operations.
The company offers a range of products and services to support drug discovery and development, including state-of-the-art facilities, cutting-edge technology, and expert scientific advice. These services include drug screening, target identification and validation, and preclinical testing. MEDICINES DISCOVERY CATAPULT LIMITED also provides training and support programs for researchers and entrepreneurs in the pharmaceutical industry.
The key people at MEDICINES DISCOVERY CATAPULT LIMITED include the CEO, Dr. Chris Molloy, and the Chairman, Dr. David Roblin. They are supported by a team of experienced scientists, researchers, and business professionals.
The company's website address is www.mdc-ltd.co.uk, where interested parties can find more information about their services, news, and events. The registered office address is 6th Floor, Nine Bond Court, Leeds, LS1 2JZ, United Kingdom.
In summary, MEDICINES DISCOVERY CATAPULT LIMITED is a leading organization in the UK that is dedicated to accelerating the discovery and development of new medicines. With a focus on sustainability, the company offers a wide range of products and services to support the pharmaceutical industry, and is led by a team of experienced professionals.
